News ArchivesRead News
Dispelling Myths about Parkinson's Disease
Sunday November 10, 2013
Craig G. Van Horne
Kentucky Herald-Leader - Parkinson's disease is one of the most common neurological disorders, affecting about 1 million Americans. Despite its prevalence and the increased awareness due to celebrities like Michael J. Fox who have Parkinson's, the disease is often misunderstood.
Parkinson's disease is a progressive neurological condition that affects movement and body functions. Its four primary effects are tremors, rigidity, slow movement and unstable posture.
The disease is caused by the death of neurons deep in the brain, which decreases the level of dopamine, a neurotransmitter involved in controlling voluntary movement. Parkinson's generally develops after age of 65, but about 15 percent of patients have a young onset form of the disease that can appear before age 50.
Here are some common myths about Parkinson's and the reality about the disease.
Myth: All individuals with Parkinson's disease have tremors, and tremors are always caused by Parkinson's disease.
Reality: While tremor is the most recognized symptom of Parkinson's disease, many Parkinson's patients do not have tremors but have rigidity and slow movements. Thirty percent of patients do not have tremors at the onset of the disease. Tremors can be caused by many other conditions.
Myth: Parkinson's disease causes individuals to have extra, uncontrolled movements.
Reality: The extra movements — called dyskinesia — associated with Parkinson's disease aren't caused by Parkinson's. They're actually a side effect of the medication used to treat the disease.
Myth: Only one part of the brain, the substantia nigra, is involved in Parkinson's disease.
Reality: The latest findings suggest that Parkinson's disease affects multiple areas of the brain.
Myth: Parkinson's disease is strictly a movement-related disease.
Reality: Because Parkinson's isease affects multiple areas of the brain, it has an array of nonmotor symptoms, including swallowing disturbances, whispering, loss of smell, cognitive difficulties, depression, loss of impulse control, sleeping problems and bladder problems/constipation.
Myth: Parkinson's Disease is caused by genetics.
Reality: There is no known cause of Parkinson's Disease. There seem to be many factors at play, including environmental and genetic factors. Only 5-10 percent of cases have a true genetic link.
Myth: Parkinson's disease is curable.
Reality: There is currently no cure for Parkinson's disease, partly because we still don't understand the causes. We need to further examine the nonmotor symptoms as possible key indicators in identifying causes and cures.
Myth: Medication is the only treatment.
Reality: There are options to treat and manage symptoms. Parkinson's disease patients are initially treated with medication, but over time it becomes less effective. The next line of treatment is deep-brain stimulation, which involves placing electrodes in the brain to regulate abnormal brain impulses. Deep-brain stimulation can be a life-changing therapy to improve quality of life and restore order to an otherwise chaotic world.
Van Horne, C.G. (10 Nov. 2013). Kentucky Herald-Leader. Dispelling Myths about Parkinson's Disease. www.kentucky.com.
Recent NewsMay 24 - Survival Rates Differ Widely in Parkinson's, MSA, Lewy Bodies
May 22 - Discovery may offer hope to Parkinson's disease patients
May 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia
May 5 - Parkinson's in a dish: Researchers reproduce brain oscillations
May 5 - ‘Hunger Hormone’ Could Help Treat Parkinson’s Disease
May 3 - Antibiotic doxycycline may offer hope for treatment of Parkinson's disease
May 1 - Impulse Control Disorders in Parkinson's Disease: Building Physician, Patient Awareness
Apr 28 - Does Parkinson’s disease begin in the gut?
Apr 28 - New empathy-creating digital device could be revolutionary for caregivers
Apr 24 - Treating Depression With Deep Brain Stimulation Works—Most of the Time
Apr 24 - Parkinson’s disease shows links to depression
Apr 21 - TOLEDO Trial: Apomorphine Infusions Reduce 'Off' Time in Parkinson's Disease
Apr 21 - New drug provides long-awaited breakthrough for Parkinson's psychosis
Apr 12 - Obstructive Sleep Apnea Affects Cognition in Parkinson's Disease
Apr 11 - Seattle boxing gym giving hope to Parkinson's patients
Apr 10 - A new rhythm
Apr 10 - Brain cells reprogrammed to make dopamine, with goal of Parkinson's therapy
Apr 6 - FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions
Apr 5 - Combatting the isolation of young onset Parkinson's disease
Apr 1 - The Kid is Alright